Sign in

CIK 0001228627

  • Non-accelerated filer
  • Smaller reporting company

Opus Genetics, Inc.

Sign in to watch
Ticker
IRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
113516358
Phone
+1 984-884-6030
Business address
8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
Former names
Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
  1. 4 Grant or award Director acquired 10,976 shares (grant or award)
  2. 4 Grant or award Director acquired 10,976 shares (grant or award)
  3. 4 Grant or award Director acquired 10,976 shares (grant or award)
  4. 4 Grant or award Director acquired 10,976 shares (grant or award)
  5. 4 Grant or award Director acquired 10,976 shares (grant or award)
  6. 4 Grant or award SVP, Operations & Bus. Dev. acquired 20,000 shares (grant or award)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Grant or award Director acquired 2,819 shares (grant or award)
  9. 4 Grant or award Director acquired 1,053 shares (grant or award)
  10. 4 Grant or award Interim CEO and President acquired 50,000 shares (grant or award)
  11. 4 Grant or award Director acquired 468 shares (grant or award)
  12. 5 Insider Annual Insider Trading Report
  13. 5 Insider Annual Insider Trading Report
  14. 4 Grant or award President and CEO acquired 134,456 shares (grant or award)
  15. 4 Grant or award Director acquired 18,544 shares (grant or award)
  16. 4 Grant or award Director acquired 13,013 shares (grant or award)
  17. 4 Grant or award Director acquired 20,822 shares (grant or award)
  18. 4 Grant or award SVP of Corp. Dev. & Ops & Sec. acquired 46,608 shares (grant or award)
  19. 4 Grant or award SVP of Finance acquired 46,608 shares (grant or award)
  20. 4 Grant or award Director acquired 16,267 shares (grant or award)

Page 7 of 21 · 403 filings